Securities in Ban For Trade Date 16-SEP-2024: 1 AARTIIND 2 BALRAMCHIN 3 BANDHANBNK 4 CHAMBLFERT 5 GRANULES 6 HINDCOPPER 7 RBLBANK Securities in Ban For Trade Date 16-SEP-2024: 1 AARTIIND 2 BALRAMCHIN 3 BANDHANBNK 4 CHAMBLFERT 5 GRANULES 6 HINDCOPPER 7 RBLBANK

Posted on by Raj Gaurav Rai

Securities in Ban For Trade Date 16-SEP-2024:
1 AARTIIND
2 BALRAMCHIN
3 BANDHANBNK
4 CHAMBLFERT
5 GRANULES
6 HINDCOPPER
7 RBLBANK Securities in Ban For Trade Date 16-SEP-2024:
1 AARTIIND
2 BALRAMCHIN
3 BANDHANBNK
4 CHAMBLFERT
5 GRANULES
6 HINDCOPPER
7 RBLBANK

Please follow and like us:

Related Posts

FIIs net longs now at 41%, which is witnessing steady improvement on daily basis, but now again a zones for them where we need to stay alert… a move above 45% net longs might act as a resistance and if we sustain that then 65% longs window opens up. Outlook for the session again positive for INDICES. NIFTY option chain reflects on a resistance at 23450 zones, so a little cautious behaviour would be wise. If sustains this then short covering rally will resume for TGTs of 23600. Buying again in declines till 23300 zones advisable, for TGTs till 23450/23600, SL 23250 then FIIs net longs now at 41%, which is witnessing steady improvement on daily basis, but now again a zones for them where we need to stay alert… a move above 45% net longs might act as a resistance and if we sustain that then 65% longs window opens up. Outlook for the session again positive for INDICES. NIFTY option chain reflects on a resistance at 23450 zones, so a little cautious behaviour would be wise. If sustains this then short covering rally will resume for TGTs of 23600. Buying again in declines till 23300 zones advisable, for TGTs till 23450/23600, SL 23250 then

FIIs net longs now at 41%, which is witnessing steady improvement on daily basis, but now again a zones for them where we need to […]

Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate Monohydrate Nasal Spray, which is equivalent to Nasonex Nasal Spray. – This new product will be launched in the first quarter of fiscal year 2025, potentially opening up new revenue streams for the company

Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate […]

TOP TECHNICAL INDICATORS TECHNICAL TOOLS: 1.MACD –INDICATOR 2.VOLUME –INDICATOR 3.BULL FLAG PATTERN 4.FIBONACCI RETRACEMENTS 5.RSI –INDICATOR 6.S/R ZONES 7.TREND LINES 8.ASCENDING CHANNEL 9.200MA–INDICATOR #StockMarket #FinancialNews #StockMarket #FinancialAdvice #Trading #NF TOP TECHNICAL INDICATORS TECHNICAL TOOLS: 1.MACD –INDICATOR 2.VOLUME –INDICATOR 3.BULL FLAG PATTERN 4.FIBONACCI RETRACEMENTS 5.RSI –INDICATOR 6.S/R ZONES 7.TREND LINES 8.ASCENDING CHANNEL 9.200MA–INDICATOR #StockMarket #FinancialNews #StockMarket #FinancialAdvice #Trading #NF

TOP TECHNICAL INDICATORS TECHNICAL TOOLS: 1.MACD –INDICATOR 2.VOLUME –INDICATOR 3.BULL FLAG PATTERN 4.FIBONACCI RETRACEMENTS 5.RSI –INDICATOR 6.S/R ZONES 7.TREND LINES 8.ASCENDING CHANNEL 9.200MA–INDICATOR #StockMarket #FinancialNews […]